Avantor Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Avantor ha aumentado sus beneficios a una tasa media anual de 58.4%, mientras que los beneficios de la industria de Life Sciences han experimentado un crecimiento de 16.4% anual. Los ingresos han ido creciendo a una tasa media de 5.4% al año. La rentabilidad financiera de Avantor es de 6.1%, y sus márgenes netos son de 4.6%.
Información clave
52.6%
Tasa de crecimiento de los beneficios
65.2%
Tasa de crecimiento del BPA
Crecimiento de la industria Life Sciences | 21.5% |
Tasa de crecimiento de los ingresos | 4.7% |
Rentabilidad financiera | 4.9% |
Margen neto | 3.8% |
Última actualización de beneficios | 31 Mar 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?
Apr 26Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear
Apr 04We Think You Can Look Beyond Avantor's (NYSE:AVTR) Lackluster Earnings
Feb 21Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 11Should You Think About Buying Avantor, Inc. (NYSE:AVTR) Now?
Jan 21Getting In Cheap On Avantor, Inc. (NYSE:AVTR) Might Be Difficult
Dec 31Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 23%?
Dec 09Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor
Dec 01These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively
Oct 24Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?
Oct 03Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?
Sep 10Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)
Sep 08Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Jul 10Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
Jun 28At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jun 22A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)
Jun 04Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Apr 17Is Avantor (NYSE:AVTR) A Risky Investment?
Apr 04Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
Mar 22Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M
Feb 03Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Feb 02Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)
Jan 28With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals
Nov 10Avantor Non-GAAP EPS of $0.34 beats by $0.01, revenue of $1.86B beats by $10M
Oct 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Oct 27Avantor raised to Buy at Citi on valuation disconnect
Oct 05Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Oct 03We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt
Sep 21Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Sep 09Avantor Non-GAAP EPS of $0.37 misses by $0.01, revenue of $1.91B misses by $70M
Jul 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Jul 18Avantor, Inc.'s (NYSE:AVTR) P/E Is On The Mark
Jul 05Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Jun 20Avantor: Narrowing The Relative Valuation Gap
May 20I Ran A Stock Scan For Earnings Growth And Avantor (NYSE:AVTR) Passed With Ease
May 15A Look At The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Apr 08Avantor: Recurrent Revenue And M&A Could Push The Stock Price Up
Mar 03Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Feb 04Here's Why We Think Avantor (NYSE:AVTR) Is Well Worth Watching
Jan 20Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Jan 05Avantor Stock: Growth At A Reasonable Price
Dec 16Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Avantor. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Mar 24 | 6,867 | 260 | 1,497 | 0 |
31 Dec 23 | 6,967 | 321 | 1,466 | 0 |
30 Sep 23 | 7,039 | 364 | 1,470 | 0 |
30 Jun 23 | 7,176 | 423 | 1,475 | 0 |
31 Mar 23 | 7,342 | 610 | 1,469 | 0 |
31 Dec 22 | 7,512 | 662 | 1,457 | 0 |
30 Sep 22 | 7,625 | 598 | 1,442 | 0 |
30 Jun 22 | 7,603 | 572 | 1,445 | 0 |
31 Mar 22 | 7,551 | 534 | 1,463 | 0 |
31 Dec 21 | 7,386 | 508 | 1,426 | 0 |
30 Sep 21 | 7,269 | 466 | 1,442 | 0 |
30 Jun 21 | 7,040 | 267 | 1,388 | 0 |
31 Mar 21 | 6,660 | 169 | 1,345 | 0 |
31 Dec 20 | 6,394 | 52 | 1,342 | 0 |
30 Sep 20 | 6,127 | 71 | 1,336 | 0 |
30 Jun 20 | 6,026 | 135 | 1,332 | 0 |
31 Mar 20 | 6,079 | -226 | 1,334 | 0 |
31 Dec 19 | 6,040 | -335 | 1,329 | 0 |
30 Sep 19 | 5,990 | -514 | 1,294 | 0 |
30 Jun 19 | 5,981 | -554 | 1,303 | 0 |
31 Mar 19 | 5,926 | -330 | 1,305 | 0 |
31 Dec 18 | 5,864 | -356 | 1,321 | 0 |
30 Sep 18 | 5,120 | -639 | 1,215 | 0 |
31 Dec 17 | 1,247 | -415 | 376 | 0 |
31 Dec 16 | 691 | -42 | 257 | 0 |
31 Dec 15 | 637 | 22 | 185 | 0 |
Ingresos de calidad: AVTR tiene un gran one-off loss de $194.2M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.
Margen de beneficios creciente: Los actuales márgenes de beneficio(4.6%) de AVTR son inferiores a los del año pasado (8.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: AVTR ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 58.4% al año.
Acelerando crecimiento: AVTR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: AVTR tuvo un crecimiento negativo de los beneficios (-51.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Life Sciences (-6.6%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AVTR (6.1%) se considera baja.